News
Technology
-
Time-resolved fluorescence immunoassay
-
Latex particle-enhanced turbidimetric immunoassay
Infection Control
Function Materials
Download
Earlier
April 2014
Lumigenex receives CFDA approval for four POCT immunoassay kits to help physicians quickly and accurately diagnose heart diseases.
March 2014
Lumigenex receives CFDA approval for five immunoassay reagents adaptable to most chemical analyzers.
February 2014
Lumigenex received CFDA approval for time-resolved fluorescence immunochromatographic analyzer.
January 2014
Dr. He Aimin was named "National Thousand Talents Program"
December 2013
Lumigenex access to "high-tech enterprises in Jiangsu Province" title.
September 2013
Lumigenex passed The first Food and Drug Administration by the Suzhou Municipal Quality Management System Assessment.